AI Article Synopsis

  • Ovarian cancer is a significant health issue in Ethiopia, with nearly 2,550 diagnoses and 2,000 deaths annually, largely influenced by lifestyle and reproductive changes.
  • This study analyzed 485 patients diagnosed between 2009 and 2015, finding a median survival of 78% at one year and 59% at two years, with a majority presenting at advanced stages (III or IV).
  • The research highlights critical treatment gaps, particularly in surgical and chemotherapy access, indicating that late-stage diagnosis and residual tumors negatively affect patient outcomes and emphasize the need for improved cancer care in Ethiopia.

Article Abstract

Background: Ovarian cancer is the third leading cause of cancer death among women in Ethiopia, with about 2,550 diagnosed cases and 2,000 deaths each year. The incidence and mortality rates of this disease have been increasing in Ethiopia and other parts of sub-Saharan Africa over the past decades because of changing lifestyle and reproductive factors. In this study, we describe the clinical characteristics, treatment patterns, and survival of patients with ovarian cancer in Ethiopia.

Materials And Methods: This retrospective cohort study included 485 patients diagnosed between January 2009 and October 2015 at Addis Ababa University Hospital, Zewditu Memorial Hospital, or registered in the Addis Ababa population-based cancer registry. Follow-up data were obtained via telephone. Primary endpoint was all-cause mortality.

Results: The median age was 46 years (range, 11-95). The estimated 1- and 2-year overall survival rates were 78% (95% confidence interval [CI] 0.741-0.82.5) and 59% (95% CI, 0.538-0.646), respectively. Of those patients with result available ( = 423), 73.0% had epithelial cancers. Almost half were classified as Federation of Gynecology and Oncology stage III or IV (48.2%; stage available = 201) resulting in worse outcomes (hazard ratio [HR], 2.91 [CI 0.67-12.64] and 3.03 [0.69-15.79], respectively). Four out of five patients received some form of surgery (82%), three out of five received platinum-containing chemotherapy. Patients with residual tumor after surgery ( = 83) showed worse survival outcome (HR, 2.23; 95% CI 1.08-4.49).

Conclusion: Our study revealed substantial treatment gaps with respect to surgery and adequate chemotherapy. Higher stage, residual tumor and lack of chemotherapy impaired the outcome. Access to higher standards of ovarian cancer treatment is urgently needed in Ethiopia.

Implications For Practice: Ovarian cancer is often a fatal disease in high resource settings; now it is also becoming important in Ethiopia. This study included 485 women with malignant ovarian tumors treated in Addis Ababa who had a mean age of only 46 years because of the young population structure. Three quarters had the typical epithelial cancer, with half presenting with advanced stage III and IV. Improved oncologic surgery and sufficient chemotherapy could possibly improve their outcome. The relatively high proportion of women with nonepithelial cancer need adequate treatment options to have good prognosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656495PMC
http://dx.doi.org/10.1634/theoncologist.2018-0869DOI Listing

Publication Analysis

Top Keywords

addis ababa
16
ovarian cancer
16
clinical characteristics
8
survival patients
8
malignant ovarian
8
ovarian tumors
8
cancer
8
study included
8
included 485
8
age years
8

Similar Publications

Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.

Clin Vaccine Immunol

August 2009

Department of Biomedical Sciences, Fisan Building, Faculty of Health Sciences, Stellenbosch University, Tygerberg Hospital Campus, Tygerberg, Cape Town, South Africa.

Increasing knowledge about DosR regulon-encoded proteins has led us to produce novel Mycobacterium tuberculosis antigens for immunogenicity testing in human populations in three countries in Africa to which tuberculosis (TB) is endemic. A total of 131 tuberculin skin test-positive and/or ESAT-6/CFP10-positive, human immunodeficiency virus-negative adult household contacts of active pulmonary TB cases from South Africa (n = 56), The Gambia (n = 26), and Uganda (n = 49) were tested for gamma interferon responses to 7 classical and 51 DosR regulon-encoded M. tuberculosis recombinant protein antigens.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!